Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,048.00
Ask: 12,054.00
Change: 698.00 (6.15%)
Spread: 6.00 (0.05%)
Open: 11,890.00
High: 12,086.00
Low: 11,790.00
Prev. Close: 11,352.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: AIM giant ASOS to move to London Main Market

Thu, 13th Jan 2022 08:24

(Alliance News) - Online fashion retailer ASOS said Thursday it plans to move to the London Main Market from AIM.

ASOS has dominated the junior market for the past 20 years as its largest, or one of its largest, stocks, with a market capitalisation of GBP2.45 billion.

"ASOS directors believe that given ASOS's size and scale, now is the appropriate time to move from AIM to a premium Main Market listing," the company said, explaining it thinks the move will raise its corporate profile and recognition, and increase investment in its shares by global institutions.

The company said it will move its listing by the end of February. JP Morgan will act as sponsor for the Main Market admission, which won't involve any fund raise.

In conjunction with the shift, ASOS has hired Patrick Kennedy as senior independent director. Kennedy, the former chief executive of Irish betting firm Paddy Power - now Flutter Entertainment - is the chair of Bank of Ireland Group.

ASOS also provided a trading update for the last four months of 2021.

Total revenue rose by 2% to GBP1.39 billion from GBP1.36 billion a year before. In constant currency, the increase was 5%. UK sales rose by 13%, while EU sales rose by 2% and US sales by 11%, both at constant currency. However, Rest of World sales fell by 15% at constant currency and by 20% at actual rates.

Gross margin narrowed by 400 basis points to 43.0%, as expected, ASOS said, due to clearance activity. The product returns rate has normalised in line with expectations.

ASOS said it full-year guidance remains unchanged at 10% to 15% revenue growth and adjusted pretax profit of GBP110 million to GBP140 million.

"Our listing on AIM for the past 20 years has been an important part of ASOS's development, but the time is now right to move to the Main Market as we focus on delivering our medium-term guidance and longer-term growth ambitions," said Chief Operating Officer Mat Dunn.

ASOS shares were up 8.5% at 2,450.00 pence.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: down 0.2% at 7,536.86

----------

Hang Seng: up 0.1% at 24,429.77

Nikkei 225: closed down 1.0% at 28,489.13

S&P/ASX 200: closed up 0.5% at 7,474.40

----------

DJIA: closed up 38.30 points, 0.1%, at 36,290.32

S&P 500: closed up 0.3% at 4,726.35

Nasdaq Composite: closed up 0.2% at 15,188.39

----------

EUR: up at USD1.1463 (USD1.1425)

GBP: up at USD1.3730 ((USD1.3693)

USD: down at JPY114.50 (JPY114.73)

Gold: up at USD1,826.88 per ounce (USD1,822.60)

Oil (Brent): down at USD84.24 a barrel (USD84.68)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's key economic events still to come

0930 GMT UK BoE quarterly bank liabilities survey

1030 EST US EIA weekly natural gas storage report

0830 EST US producer price index

0830 EST US initial jobless claims

----------

A second consecutive day of almost unilaterally negative coverage by the press of UK Prime Minister Boris Johnson features widespread calls for his resignation after his apology during Prime Minister's Questions. Johnson admitted at the beginning of PMQs he attended a lockdown party in the No 10 garden on 20 May, 2020. He offered an apology but said he thought it classified as a work event and therefore would fall within the rules. In response to repeated calls to resign from members of opposition parties, including Labour Leader Keir Starmer, Johnson asked an official inquiry be allowed to "establish the facts". Much of Thursday's media coverage focused on growing discontent within the PM's own party. The Guardian says his future is on a 'knife's-edge', with some Conservative MPs openly calling for his resignation while others speak off-the-record.

----------

BROKER RATING CHANGES

----------

Jefferies raises Mears Group to 'Buy' (Hold) - price target 275 (210) pence

----------

BofA cuts IAG to 'Neutral' (Buy) - price target 180 (240) pence

----------

Morgan Stanley resumes Smiths Group with 'Equal-Weight' - target 1,580 pence

----------

COMPANIES - FTSE 100

----------

Tesco, the UK's largest supermarket chain, said it delivered a strong third quarter and Christmas trading performance, bolstered by the grocer's "unwavering" commitment to value for customers. For the 19 weeks to January 8, like-for-like retail sales were up 2.6% compared to the same period the year before. Over the Christmas period alone, like-for-like sales grew 3.2% year-on-year. Tesco said as a result of stronger-than-expected sales to date, it now expects retail operating profit for financial 2022 slightly above the top-end of its previous GBP2.5 billion to GBP2.6 billion guidance range. It posted retail operating profit of GBP1.99 billion in financial 2021. "Despite growing cost pressures and supply chain challenges in the industry, we continued to invest to protect availability, doubled down on our commitment to deliver great value and offered our strongest ever festive range. This put us in a strong position to meet customers' needs as, once again, Covid-19 led to a greater focus on celebrating at home. As a result, we outperformed the market, growing market share and strengthening our value position," said Chief Executive Officer Ken Murphy.

----------

Housebuilder Persimmon hailed its "excellent" performance throughout 2021 and said the long-term fundamentals of the UK housing market remain strong. Persimmon said it delivered 14,551 new home completions in 2021, up from 13,575 in 2020, with an average selling price of GBP237,050, up from GBP230,534. The York-based housebuilder said total revenue in 2021 was GBP3.61 billion, up from GBP3.33 billion in 2020. New housing revenue was GBP3.45 billion, up from GBP3.13 billion. Addressing sector concerns, Persimmon said it agreed with the UK government that leaseholders should not have to pay to remove flammable cladding. Persimmon said it constructed only a "very small proportion" of buildings affected by this issue, which caused the deadly fire at the Grenfell Tower in 2017. In common with the rest of the housebuilding industry, it will shortly begin paying the cladding levy announced in the UK budget, it noted.

----------

In addition, Persimmon appointed Jason Windsor as its new chief financial officer, hired from insurer Aviva to succeed Mike Killoran, who will be retiring in mid-January. Aviva noted the announcement and said a search for a new CFO is underway.

----------

Pharmaceutical firm AstraZeneca has signed a collaboration agreement with Scorpion Therapeutics. Astra will pay Scorpion USD75 million upfront in cash and will have an exclusive over up to three drugs developed using the Scorpion drug discovery platform. The partnership will develop oncology treatments, focusing on hard-to-target cancer proteins. "The new collaboration focuses on a class of proteins called transcription factors, which control gene expression and can regulate important cellular processes including cell growth and survival," Astra explained. "Many transcription factors have long been identified as important targets for new cancer treatments and as drivers of disease, but have previously been considered 'undruggable' using conventional drug discovery approaches."

----------

COMPANIES - FTSE 250

----------

Food, clothing and homewares retailer Marks & Spencer said it put in a strong performance in its financial third quarter and over the Christmas period. For the 13 weeks to January 1, group sales were GBP3.27 billion, up 19% from the same time a year before. As a result of performance over the period, M&S said it was more confident of its ability to deliver the increased guidance it set, and now expects full-year profit before tax and adjusting items of at least GBP500 million. "Trading over the Christmas period has been strong, demonstrating the continued improvements we've made to product and value. Clothing & Home has delivered growth for the second successive quarter, supported by robust online and full price sales growth. Food has maintained its momentum, outperforming the market over both 12 and 24 months," said CEO Steve Rowe.

----------

COMPANIES - GLOBAL

----------

Crown Resorts said it has received a revised takeover proposal from US private equity firm Blackstone. The Australian gambling operator said the offer was AUD13.10 per Crown Resorts share in cash. This is a AUD0.60 increase compared to Blackstone's previous offer of AUD12.50 per share in cash received back in November and is the third offer by Blackstone. Blackstone's original offer was for AUD11.85 per share in cash. Crown shares closed up 8.8% to AUD12.65 in Sydney on Thursday. Blackstone already has a 10% stake in Crown Resorts, having bought the shares from Melco Resorts & Entertainment Ltd for AUD8.15 per share in April 2020.

----------

Thursday's shareholder meetings

Blue Prism Group PLC - GM re takeover by SS&C Technologies

Centrica PLC - GM re sale of Spirit Energy

JPMorgan Japanese Investment Trust PLC - AGM

Kefi Gold & Copper PLC - GM re share placing

Victoria PLC - GM re issue of preferred shares

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
Today 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
Today 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
Today 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more
Today 07:43

LONDON BRIEFING: Miner Anglo American eyes rival BHP takeover

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
Today 06:30

Sanofi Q1 profit slips on generic competition, forex effects

April 25 (Reuters) - Sanofi's said on Thursday first-quarter operating income declined 14.7% as unfavourable currency effects and cheap competition to multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.